Report Cover

Global and United States Drug of Abuse (DOA) Testing Market Report & Forecast 2022-2028


Drug of Abuse (DOA) Testing market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Drug of Abuse (DOA) Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Drug of Abuse (DOA) Testing market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
    Urine
    Saliva
    Hair
    Others
Segment by Application
    Hospitals
    Laboratories
    Workplace
    At-Home
    Others
By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        U.A.E
By Company
    Siemens
    Merck
    Roche
    Thermo Fisher Scientific
    Bio-Rad
    Abbott
    Quest Diagnostics
    Psychemedics
1 Study Coverage
    1.1 Drug of Abuse (DOA) Testing Revenue in Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Drug of Abuse (DOA) Testing Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Drug of Abuse (DOA) Testing Market Size for the Year 2017-2028
        1.2.2 Global Drug of Abuse (DOA) Testing Market Size for the Year 2017-2028
    1.3 Drug of Abuse (DOA) Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Drug of Abuse (DOA) Testing in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Drug of Abuse (DOA) Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Drug of Abuse (DOA) Testing Market Dynamics
        1.4.1 Drug of Abuse (DOA) Testing Industry Trends
        1.4.2 Drug of Abuse (DOA) Testing Market Drivers
        1.4.3 Drug of Abuse (DOA) Testing Market Challenges
        1.4.4 Drug of Abuse (DOA) Testing Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Drug of Abuse (DOA) Testing by Type
    2.1 Drug of Abuse (DOA) Testing Market Segment by Type
        2.1.1 Urine
        2.1.2 Saliva
        2.1.3 Hair
        2.1.4 Others
    2.2 Global Drug of Abuse (DOA) Testing Market Size by Type (2017, 2022 & 2028)
    2.3 Global Drug of Abuse (DOA) Testing Market Size by Type (2017-2028)
    2.4 United States Drug of Abuse (DOA) Testing Market Size by Type (2017, 2022 & 2028)
    2.5 United States Drug of Abuse (DOA) Testing Market Size by Type (2017-2028)
3 Drug of Abuse (DOA) Testing by Application
    3.1 Drug of Abuse (DOA) Testing Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Laboratories
        3.1.3 Workplace
        3.1.4 At-Home
        3.1.5 Others
    3.2 Global Drug of Abuse (DOA) Testing Market Size by Application (2017, 2022 & 2028)
    3.3 Global Drug of Abuse (DOA) Testing Market Size by Application (2017-2028)
    3.4 United States Drug of Abuse (DOA) Testing Market Size by Application (2017, 2022 & 2028)
    3.5 United States Drug of Abuse (DOA) Testing Market Size by Application (2017-2028)
4 Global Drug of Abuse (DOA) Testing Competitor Landscape by Company
    4.1 Global Drug of Abuse (DOA) Testing Market Size by Company
        4.1.1 Top Global Drug of Abuse (DOA) Testing Companies Ranked by Revenue (2021)
        4.1.2 Global Drug of Abuse (DOA) Testing Revenue by Player (2017-2022)
    4.2 Global Drug of Abuse (DOA) Testing Concentration Ratio (CR)
        4.2.1 Drug of Abuse (DOA) Testing Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Drug of Abuse (DOA) Testing in 2021
        4.2.3 Global Drug of Abuse (DOA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Drug of Abuse (DOA) Testing Headquarters, Revenue in Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Drug of Abuse (DOA) Testing Headquarters and Area Served
        4.3.2 Global Drug of Abuse (DOA) Testing Companies Revenue in Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Drug of Abuse (DOA) Testing Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Drug of Abuse (DOA) Testing Market Size by Company
        4.5.1 Top Drug of Abuse (DOA) Testing Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Drug of Abuse (DOA) Testing Revenue by Players (2020, 2021 & 2022)
5 Global Drug of Abuse (DOA) Testing Market Size by Region
    5.1 Global Drug of Abuse (DOA) Testing Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Drug of Abuse (DOA) Testing Market Size by Region (2017-2028)
        5.2.1 Global Drug of Abuse (DOA) Testing Market Size by Region: 2017-2022
        5.2.2 Global Drug of Abuse (DOA) Testing Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Drug of Abuse (DOA) Testing Market Size YoY Growth 2017-2028
        6.1.2 North America Drug of Abuse (DOA) Testing Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Drug of Abuse (DOA) Testing Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Drug of Abuse (DOA) Testing Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Drug of Abuse (DOA) Testing Market Size YoY Growth 2017-2028
        6.3.2 Europe Drug of Abuse (DOA) Testing Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Drug of Abuse (DOA) Testing Market Size YoY Growth 2017-2028
        6.4.2 Latin America Drug of Abuse (DOA) Testing Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Drug of Abuse (DOA) Testing Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Drug of Abuse (DOA) Testing Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Siemens
        7.1.1 Siemens Company Details
        7.1.2 Siemens Business Overview
        7.1.3 Siemens Drug of Abuse (DOA) Testing Introduction
        7.1.4 Siemens Revenue in Drug of Abuse (DOA) Testing Business (2017-2022)
        7.1.5 Siemens Recent Development
    7.2 Merck
        7.2.1 Merck Company Details
        7.2.2 Merck Business Overview
        7.2.3 Merck Drug of Abuse (DOA) Testing Introduction
        7.2.4 Merck Revenue in Drug of Abuse (DOA) Testing Business (2017-2022)
        7.2.5 Merck Recent Development
    7.3 Roche
        7.3.1 Roche Company Details
        7.3.2 Roche Business Overview
        7.3.3 Roche Drug of Abuse (DOA) Testing Introduction
        7.3.4 Roche Revenue in Drug of Abuse (DOA) Testing Business (2017-2022)
        7.3.5 Roche Recent Development
    7.4 Thermo Fisher Scientific
        7.4.1 Thermo Fisher Scientific Company Details
        7.4.2 Thermo Fisher Scientific Business Overview
        7.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Introduction
        7.4.4 Thermo Fisher Scientific Revenue in Drug of Abuse (DOA) Testing Business (2017-2022)
        7.4.5 Thermo Fisher Scientific Recent Development
    7.5 Bio-Rad
        7.5.1 Bio-Rad Company Details
        7.5.2 Bio-Rad Business Overview
        7.5.3 Bio-Rad Drug of Abuse (DOA) Testing Introduction
        7.5.4 Bio-Rad Revenue in Drug of Abuse (DOA) Testing Business (2017-2022)
        7.5.5 Bio-Rad Recent Development
    7.6 Abbott
        7.6.1 Abbott Company Details
        7.6.2 Abbott Business Overview
        7.6.3 Abbott Drug of Abuse (DOA) Testing Introduction
        7.6.4 Abbott Revenue in Drug of Abuse (DOA) Testing Business (2017-2022)
        7.6.5 Abbott Recent Development
    7.7 Quest Diagnostics
        7.7.1 Quest Diagnostics Company Details
        7.7.2 Quest Diagnostics Business Overview
        7.7.3 Quest Diagnostics Drug of Abuse (DOA) Testing Introduction
        7.7.4 Quest Diagnostics Revenue in Drug of Abuse (DOA) Testing Business (2017-2022)
        7.7.5 Quest Diagnostics Recent Development
    7.8 Psychemedics
        7.8.1 Psychemedics Company Details
        7.8.2 Psychemedics Business Overview
        7.8.3 Psychemedics Drug of Abuse (DOA) Testing Introduction
        7.8.4 Psychemedics Revenue in Drug of Abuse (DOA) Testing Business (2017-2022)
        7.8.5 Psychemedics Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables Table 1. Drug of Abuse (DOA) Testing Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Drug of Abuse (DOA) Testing Market Trends Table 3. Drug of Abuse (DOA) Testing Market Drivers Table 4. Drug of Abuse (DOA) Testing Market Challenges Table 5. Drug of Abuse (DOA) Testing Market Restraints Table 6. Global Drug of Abuse (DOA) Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Drug of Abuse (DOA) Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Drug of Abuse (DOA) Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Drug of Abuse (DOA) Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Drug of Abuse (DOA) Testing Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Drug of Abuse (DOA) Testing Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Drug of Abuse (DOA) Testing Revenue Share by Player, 2017-2022 Table 13. Global Drug of Abuse (DOA) Testing Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Drug of Abuse (DOA) Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug of Abuse (DOA) Testing as of 2021) Table 15. Top Players of Drug of Abuse (DOA) Testing in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Drug of Abuse (DOA) Testing Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Drug of Abuse (DOA) Testing Players in United States Market, Ranking by Revenue (2021) Table 20. United States Drug of Abuse (DOA) Testing Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Drug of Abuse (DOA) Testing Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Drug of Abuse (DOA) Testing Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Drug of Abuse (DOA) Testing Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Drug of Abuse (DOA) Testing Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Drug of Abuse (DOA) Testing Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Drug of Abuse (DOA) Testing Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Drug of Abuse (DOA) Testing Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Drug of Abuse (DOA) Testing Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Drug of Abuse (DOA) Testing Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Siemens Company Details Table 31. Siemens Business Overview Table 32. Siemens Drug of Abuse (DOA) Testing Product Table 33. Siemens Revenue in Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million) Table 34. Siemens Recent Development Table 35. Merck Company Details Table 36. Merck Business Overview Table 37. Merck Drug of Abuse (DOA) Testing Product Table 38. Merck Revenue in Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million) Table 39. Merck Recent Development Table 40. Roche Company Details Table 41. Roche Business Overview Table 42. Roche Drug of Abuse (DOA) Testing Product Table 43. Roche Revenue in Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million) Table 44. Roche Recent Development Table 45. Thermo Fisher Scientific Company Details Table 46. Thermo Fisher Scientific Business Overview Table 47. Thermo Fisher Scientific Drug of Abuse (DOA) Testing Product Table 48. Thermo Fisher Scientific Revenue in Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million) Table 49. Thermo Fisher Scientific Recent Development Table 50. Bio-Rad Company Details Table 51. Bio-Rad Business Overview Table 52. Bio-Rad Drug of Abuse (DOA) Testing Product Table 53. Bio-Rad Revenue in Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million) Table 54. Bio-Rad Recent Development Table 55. Abbott Company Details Table 56. Abbott Business Overview Table 57. Abbott Drug of Abuse (DOA) Testing Product Table 58. Abbott Revenue in Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million) Table 59. Abbott Recent Development Table 60. Quest Diagnostics Company Details Table 61. Quest Diagnostics Business Overview Table 62. Quest Diagnostics Drug of Abuse (DOA) Testing Product Table 63. Quest Diagnostics Revenue in Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million) Table 64. Quest Diagnostics Recent Development Table 65. Psychemedics Company Details Table 66. Psychemedics Business Overview Table 67. Psychemedics Drug of Abuse (DOA) Testing Product Table 68. Psychemedics Revenue in Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million) Table 69. Psychemedics Recent Development Table 70. Research Programs/Design for This Report Table 71. Key Data Information from Secondary Sources Table 72. Key Data Information from Primary Sources List of Figures Figure 1. Drug of Abuse (DOA) Testing Product Picture Figure 2. Global Drug of Abuse (DOA) Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Drug of Abuse (DOA) Testing Market Size 2017-2028 (US$ Million) Figure 4. United States Drug of Abuse (DOA) Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Drug of Abuse (DOA) Testing Market Size 2017-2028 (US$ Million) Figure 6. United States Drug of Abuse (DOA) Testing Market Share in Global 2017-2028 Figure 7. Drug of Abuse (DOA) Testing Report Years Considered Figure 8. Product Picture of Urine Figure 9. Product Picture of Saliva Figure 10. Product Picture of Hair Figure 11. Product Picture of Others Figure 12. Global Drug of Abuse (DOA) Testing Market Share by Type in 2022 & 2028 Figure 13. Global Drug of Abuse (DOA) Testing Market Size by Type (2017-2028) & (US$ Million) Figure 14. Global Drug of Abuse (DOA) Testing Market Share by Type (2017-2028) Figure 15. United States Drug of Abuse (DOA) Testing Market Share by Type in 2022 & 2028 Figure 16. United States Drug of Abuse (DOA) Testing Market Size by Type (2017-2028) & (US$ Million) Figure 17. United States Drug of Abuse (DOA) Testing Market Share by Type (2017-2028) Figure 18. Product Picture of Hospitals Figure 19. Product Picture of Laboratories Figure 20. Product Picture of Workplace Figure 21. Product Picture of At-Home Figure 22. Product Picture of Others Figure 23. Global Drug of Abuse (DOA) Testing Market Share by Application in 2022 & 2028 Figure 24. Global Drug of Abuse (DOA) Testing Market Size by Application (2017-2028) & (US$ Million) Figure 25. Global Drug of Abuse (DOA) Testing Market Share by Application (2017-2028) Figure 26. United States Drug of Abuse (DOA) Testing Market Share by Application in 2022 & 2028 Figure 27. United States Drug of Abuse (DOA) Testing Market Size by Application (2017-2028) & (US$ Million) Figure 28. United States Drug of Abuse (DOA) Testing Market Share by Application (2017-2028) Figure 29. North America Drug of Abuse (DOA) Testing Market Size Growth Rate 2017-2028 (US$ Million) Figure 30. U.S. Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. Canada Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 32. Europe Drug of Abuse (DOA) Testing Market Size Growth Rate 2017-2028 (US$ Million) Figure 33. Germany Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. France Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 35. U.K. Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. Italy Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. Russia Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. Asia-Pacific Drug of Abuse (DOA) Testing Market Size Growth Rate 2017-2028 (US$ Million) Figure 39. China Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. Japan Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. South Korea Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. India Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Australia Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Taiwan Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Indonesia Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 46. Thailand Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Malaysia Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Philippines Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Latin America Drug of Abuse (DOA) Testing Market Size Growth Rate 2017-2028 (US$ Million) Figure 50. Mexico Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Brazil Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. Argentina Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. Middle East & Africa Drug of Abuse (DOA) Testing Market Size Growth Rate 2017-2028 (US$ Million) Figure 54. Turkey Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 55. Saudi Arabia Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 56. U.A.E Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 57. Siemens Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2017-2022) Figure 58. Merck Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2017-2022) Figure 59. Roche Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2017-2022) Figure 60. Thermo Fisher Scientific Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2017-2022) Figure 61. Bio-Rad Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2017-2022) Figure 62. Abbott Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2017-2022) Figure 63. Quest Diagnostics Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2017-2022) Figure 64. Psychemedics Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2017-2022) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us